Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. First Solar, Inc. Industry Stock Comparison

Buy
57

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$24.97
Seasonality Move:
7.92%
Buy
63

FSLR
First Solar, Inc.

Last Price:
$272.73
Seasonality Move:
4.47%
Buy
57
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $24.97. The Score for APLS is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
First Solar, Inc. (FSLR) is a Buy

Is First Solar, Inc. a Buy, Sell or Hold?

  • The current First Solar, Inc. [FSLR] share price is $272.83. The Score for FSLR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • FSLR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $24.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight selling pressure.

FSLR Stock Price Chart

What is First Solar, Inc.'s stock price today?

  • The First Solar, Inc. share price today is $272.83
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FSLR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.54 Buy
Relative Strength Index (14 RSI): 67.36 Buy
Chaikin Money Flow: -208746 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.29 - 22.81) Buy
Bollinger Bands (100): (20.75 - 26.93) Buy

FSLR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.49 Buy
Relative Strength Index (14 RSI): 61.64 Buy
Chaikin Money Flow: 2167125 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (252.67 - 268.43) Buy
Bollinger Bands (100): (194.77 - 253.67) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.12 Buy
20-day SMA: 21.44 Buy
50-day SMA: 23.06 Buy
200-day SMA: 21.92 Buy
8-day EMA: 23.44 Buy
20-day EMA: 22.39 Buy
50-day EMA: 22.63 Buy
200-day EMA: 24.24 Buy

FSLR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 259.73 Buy
20-day SMA: 258.49 Buy
50-day SMA: 249.49 Buy
200-day SMA: 185.82 Buy
8-day EMA: 261.83 Buy
20-day EMA: 259.26 Buy
50-day EMA: 247.87 Buy
200-day EMA: 208.06 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

First Solar, Inc. Earnings Growth & FSLR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $8.93 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

First Solar, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):